Sinovac Biotech Ltd (SVA) — Cash Flow-to-Debt Ratio
Sinovac Biotech Ltd (SVA) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2023, meaning its operating cash flow of $146.01 Million could theoretically repay 0% of its total liabilities ($1.64 Billion) in one year. See Sinovac Biotech Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sinovac Biotech Ltd Cash Flow-to-Debt Ratio (2000–2025)
Historical debt coverage capacity for Sinovac Biotech Ltd across 26 annual periods. For the full cash flow conversion analysis, see Sinovac Biotech Ltd operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Sinovac Biotech Ltd (2000–2025)
Year-by-year debt coverage analysis for Sinovac Biotech Ltd. Check cash flow quality index of Sinovac Biotech Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.23x | $-510.49 Million | $2.23 Billion | ▼ -721.2% |
| 2024 | -0.03x | $-56.89 Million | $2.04 Billion | ▼ -142.9% |
| 2023 | 0.06x | $106.02 Million | $1.64 Billion | ▲ +111.8% |
| 2022 | -0.55x | $-770.75 Million | $1.40 Billion | ▼ -110.3% |
| 2021 | 5.35x | $15.35 Billion | $2.87 Billion | ▲ +771.2% |
| 2020 | 0.61x | $479.31 Million | $781.20 Million | ▲ +57.2% |
| 2019 | 0.39x | $39.07 Million | $100.10 Million | ▲ +282.6% |
| 2018 | 0.10x | $7.94 Million | $77.85 Million | ▼ -86.1% |
| 2017 | 0.73x | $59.76 Million | $81.69 Million | ▲ +486.5% |
| 2016 | -0.19x | $-15.46 Million | $81.69 Million | ▼ -398.5% |
| 2015 | 0.06x | $4.21 Million | $66.42 Million | ▲ +160.6% |
| 2014 | -0.10x | $-10.13 Million | $96.80 Million | ▼ -282.1% |
| 2013 | 0.06x | $5.58 Million | $97.05 Million | ▲ +128.0% |
| 2012 | -0.20x | $-16.25 Million | $79.33 Million | ▼ -203.8% |
| 2011 | 0.20x | $13.94 Million | $70.61 Million | ▲ +192.1% |
| 2010 | -0.21x | $-14.28 Million | $66.60 Million | ▼ -127.0% |
| 2009 | 0.79x | $48.41 Million | $61.01 Million | ▲ +79.8% |
| 2008 | 0.44x | $10.50 Million | $23.80 Million | ▲ +151.0% |
| 2007 | 0.18x | $4.32 Million | $24.55 Million | ▲ +268.8% |
| 2006 | -0.10x | $-1.64 Million | $15.70 Million | ▲ +36.8% |
| 2005 | -0.16x | $-1.13 Million | $6.86 Million | ▲ +26.5% |
| 2004 | -0.22x | $-1.54 Million | $6.86 Million | ▲ +47.8% |
| 2003 | -0.43x | $-1.72 Million | $4.01 Million | ▼ -1.3% |
| 2002 | -0.42x | $-58.05K | $136.81K | ▲ +18.4% |
| 2001 | -0.52x | $-494.80K | $952.15K | ▲ +0.0% |
| 2000 | -0.52x | $-494.80K | $952.15K | — |